Feb 17, 2026 07:42AM
Dec 12, 2025 08:45AM
Dec 12, 2025 08:45AM
Dec 1, 2025 08:45AM
Dec 1, 2025 08:45AM
Nov 4, 2025 07:30AM
Nov 3, 2025 08:30AM Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
Oct 27, 2025 07:00AM
Oct 27, 2025 07:00AM
Oct 24, 2025 08:30AM
Oct 24, 2025 08:30AM
Oct 13, 2025 12:10PM
Oct 13, 2025 08:30AM
Jul 31, 2025 08:31AM Actinium presents preclinical data for ATNM-400 prostate cancer therapy
Jul 31, 2025 08:30AM
Jun 23, 2025 11:31AM
Jun 23, 2025 11:30AM
May 26, 2025 10:20AM
May 25, 2025 09:03AM
May 24, 2025 08:50AM
May 22, 2025 04:00PM ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 22, 2025 09:00AM
May 21, 2025 09:53AM
May 19, 2025 06:40PM
May 18, 2025 10:00AM
May 17, 2025 08:03AM
May 16, 2025 04:00PM
May 15, 2025 10:20AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
May 13, 2025 09:00AM
May 12, 2025 05:48PM
May 11, 2025 04:00PM
May 10, 2025 08:04AM
May 9, 2025 08:00AM
May 6, 2025 08:45AM
May 5, 2025 04:00PM ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 5, 2025 11:12AM
May 5, 2025 10:11AM
May 2, 2025 10:19AM
Apr 29, 2025 04:00PM
Apr 29, 2025 10:21AM
Apr 28, 2025 08:36AM
Apr 28, 2025 08:30AM Actinium Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models at the American Association for Cancer Res
Apr 28, 2025 08:00AM
Apr 25, 2025 12:02PM
Apr 23, 2025 04:00PM
Apr 22, 2025 09:30AM
Apr 21, 2025 12:26PM
Apr 17, 2025 04:00PM
Apr 17, 2025 11:50AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
Apr 17, 2025 11:35AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All